Apple will sell AirPods with hearing aids built in
By
Haymarket Media
Sep 10, 2024
It’s designed as an over-the-counter hearing aid feature for those with mild to moderate hearing loss.
Semaglutide reduces risk for MACE in patients with obesity and heart failure
By
Haymarket Media
Aug 28, 2024
MACE, heart failure composite end point, cardiovascular death and all-cause death all improved with semaglutide for patients with versus without heart failure.
Psychological well-being declines years before diagnosis of MCI
Aug 20, 2024
The findings were seen specifically for the components of purpose in life and personal growth.
USDA toughens rules on salmonella in poultry
Jul 30, 2024
Chicken, turkey and other poultry might get a little safer after new rules to limit salmonella proposed Monday by the US Department of Agriculture.
FDA delays decision on new Alzheimer’s drug
Mar 08, 2024
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely...
EPA proposes removing 100 percent of lead pipes from US water system
Nov 30, 2023
Utility companies expected to cover most of the cost, but there is $15 billion available in the 2021 infrastructure law to help
Rite Aid pharmacy chain files for bankruptcy
Oct 16, 2023
Rite Aid will stay open through bankruptcy but speed up certain store closings and sell Elixir Solutions, a prescription benefit provider.
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
In early trial, results promising for Moderna combo COVID-flu vaccine
Oct 05, 2023
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025.